Anlito, Sandro M.
HRN: 23-58-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/29/2023
09/05/2023
IV
750mg
TID
AGE W/ MOD. DHN
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes